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Background: Colorectal cancer (CRC) is one of the main cancer types, with high incidence 
and mortality in Norway. We examined the association between different measures of smoking 
exposure and CRC mortality overall and by subsite in a large Norwegian cohort.
Methods: We followed 602,242 participants from four Norwegian health surveys, aged 19–67 
years at enrollment between 1972 and 2003 by linkage to the national registries through Decem-
ber 2007. We used Cox proportional hazard models to estimate hazard ratios (HRs) and 95% 
confidence intervals (CIs) by smoking categories for different CRC endpoints.
Results: During a mean follow-up of 14 years, 2,333 Norwegian males and females died of CRC 
(60% men). Male and female ever smokers had a 20% (HR 1.23, CI 1.08–1.40 and HR 1.22, 95% 
CI 1.06–1.40, respectively) increased risk of death from CRC compared with sex-specific never 
smokers. For proximal colon cancer mortality, female ever smokers had a 50% (HR 1.49, 95% 
CI 1.20–1.87) increased risk compared with female never smokers. The increased risk of rectal 
cancer mortality was about 40% higher for male ever smokers (HR 1.43, 95% CI 1.14–1.81) 
compared with male never smokers. A test for heterogeneity by sex showed an increased risk of 
rectal cancer mortality among men which was significant for former smokers (Wald χ2=0.02) 
and an increased risk of proximal colon cancer mortality among women which was significant 
for ever and former smokers (Wald χ2=0.02 and χ2=0.04, respectively).
Conclusion: Smoking is associated with increased CRC mortality in both sexes. The risk 
of rectal and proximal colon cancer mortality was most pronounced among male and female 
smokers respectively.
Keywords: colorectal cancer, mortality, cigarette smoking, sex, cohort study, Norway
Introduction
Colorectal cancer (CRC) accounts for 8% of all cancer deaths, making it the fourth 
most common cause of death from cancer worldwide.1 CRC is the second most 
 common cause of cancer death in Europe.2 Worldwide, mortality rates are lower in 
women than in men except in the Caribbean region.1 In Norway, the incidence of CRC 
is the second highest after breast cancer among women and third highest after lung 
and  prostate cancer in men. The 5-year incidence of CRC was 43 for men and 35 for 
women per 100,000 person-years in 2007 to 2011, which is adjusted to the world 
population. However, the mortality rate for CRC ranks third among men after lung 
and prostate cancer and second among women after lung cancer.3
Cigarette smoking is the major preventable and modifiable cause of death 
 worldwide.4 The World Health Organization has reported that almost 100 mil-
lion deaths were caused by cigarette smoking in the 20th century, and if this trend 





continues, another one billion smoking-related deaths are 
expected in the 21st century.5 Presently, smoking is attrib-
uted to approximately 6 million premature deaths  annually 
worldwide. If prevention measures are not implemented 
soon, the death toll is expected to reach 8 million per year 
by 2030. The casual association between cigarette smoking 
and CRC was recently re-evaluated by an expert group from 
the International Agency for Research on Cancer,6 with the 
conclusion that smoking is a risk factor for both colon and 
rectal cancer. It has been proposed that about 12% of CRC 
deaths are attributable to smoking.7,8
The prevalence of smoking in Norway for men was about 
52% in 1973; by 2007, there had been more than a 50% reduc-
tion to 24%. The proportion of women smokers remained 
at around 30% from 1973 to 2002. After 2002, there was 
a substantial decline in women who smoked daily, and the 
prevalence of women smokers was similar to that of men by 
2007.9–11 We have previously reported that the increased risk 
of colon cancer due to cigarette smoking may be greater in 
women than in men.12
The main purpose of this study was to prospectively 
examine the association between cigarette smoking and CRC 
mortality in a large Norwegian cohort. We also wanted to 
investigate if the association differed by sex.
Materials and methods
study population
Our study included 652,792 subjects (49% men) who 
 participated in several Norwegian health surveys (the Oslo 
study I, the Norwegian Counties study, the 40 years cohort, 
and the Cohort of Norway [CONOR]). These surveys were 
conducted between 1972 and 2003, and were merged into 
one database which constitutes the basis of the present 
study. Our study was approved by the Regional Com-
mittee for Medical Research Ethics South-East Norway. 
Detailed information on the study population can be found 
elsewhere.12,13
Exposure information
All surveys had a baseline questionnaire that included a 
detailed assessment of smoking habits, physical activity, 
and other lifestyle factors. The questionnaires included 
questions on current and former smoking habits, smoking 
duration, and average number of cigarettes smoked per day; 
some also asked about age at smoking initiation. Current 
smokers were defined as those who were daily smokers, and 
former smokers were classified according to years since 
quitting smoking, or if they answered that they had smoked 
previously, but were not smokers at the time of enrollment. 
Current and former smokers were also classified as ever 
smokers, and categorized according to the following factors 
at enrollment: age at smoking initiation, average number of 
cigarettes smoked per day, smoking duration in years, and 
number of pack-years (ie, number of cigarettes smoked per 
day, divided by 20, multiplied by the duration of smoking, 
in years). Only the CONOR study asked about the age at 
smoking initiation. In other surveys, we calculated age at 
smoking initiation for both current (ie, age at enrollment 
minus duration of smoking, in years) and for former  smokers 
(age at quitting smoking minus duration of smoking, in 
years). Participants who were neither current nor former 
smokers were classified as never smokers. Body mass index 
was calculated as weight in  kilograms divided by the square 
of height, in meters. The participants were categorized into 
three groups based on the level of physical activity reported 
in the baseline questionnaires: a sedentary group (reading, 
watching television, and sedentary activity ,4 hours a week); 
a moderate group (walking,  bicycling, or similar activities $4 
hours a week); and a heavy physical activity group (heavy 
exercise and daily competitive sports, and light sports, or 
heavy gardening $4 hours a week).  Information regarding 
duration of education was obtained from Statistics Norway 
and participants were assigned to one of the three categories 
by duration of education, ie, less than 10 years, 10–12 years, 
and 13 or more years.
Follow-up and endpoints
The participants were linked to the Cancer Registry of 
Norway, the Norwegian Cause of Death Registry, and the 
Central Population Register. The unique 11-digit personal 
identification number was utilized to identify all cancer 
deaths and emigration respectively. The national registries 
contain correct and detailed information regarding cancer 
incidence and mortality.14 CRC mortality was classified 
according to the ninth and tenth revisions of the International 
Statistical Classification of Diseases. Follow-up ended at the 
time of death from primary CRC cancer, death from any other 
cancer (except basal cell carcinoma of the skin), emigration, 
death from other causes, or December 31, 2007, whichever 
occurred first.
We excluded 11,476 subjects who were diagnosed 
with any invasive cancer prior to the start of the study, and 
1,009  subjects who emigrated or died before the start of 
 follow-up. We further excluded 6,299 subjects with insuf-
ficient  information on smoking history. Finally, we excluded 
those with missing information on body mass index (n=5,107), 
physical activity (n=8,210), or education (n=18,449), 
leaving 602,242 (49.7% men) in the analytical cohort.
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statistical analysis
We used Student’s t-test and χ2 test to investigate the distri-
bution of selected characteristics between current and never 
smokers. All analyses were conducted separately by sex. The 
Cox proportional hazards model was used with age as the 
 underlying time scale to estimate multivariate-adjusted hazard 
ratios (HRs) with 95% confidence intervals (CIs) for the asso-
ciations between different measures of smoking exposure and 
colorectal, colon, and rectal cancer deaths with never smokers 
as the reference group. Entry time was defined as age at enroll-
ment and exit time was age at death, emigration, or end of 
follow-up (December 31, 2007), whichever occurred first. The 
ever smoking variables were analyzed separately for males 
and females. These were: age at smoking initiation in years 
(#19, 20–24, $25), numbers of cigarettes smoked per day 
(1–9, 10–19, $20), smoking duration in years (1–19, 20–29, 
$30), and number of pack-years (0–9, 10–19, $20).
Possible confounders included in the final models, 
selected a priori, were age (continuous), level of physi-
cal activity (sedentary, moderate, heavy), and body mass 
index (continuous) at enrollment, and years of education 
(,10 years, 10–12 years, $13 years). Tests for linear trends 
were obtained by creating an ordinal exposure variable with 
equally spaced scores and including it in the models, and 
we performed the trend tests with never smokers included. 
We reanalyzed the data excluding the 8,151 (99% men) 
subjects who reported smoking only cigars or a pipe. We had 
information on alcohol consumption for 37% (n=221,748) of 
participants. We undertook sensitivity analyses by sex for the 
main outcomes based on this population (49% men) enrolled 
after 1995. Heterogeneity by sex with regard to the effect of 
smoking and risk of CRC mortality was tested with the Wald 
χ2. Two-sided P-values ,0.05 were considered to be statisti-
cally significant. All analyses were conducted using STATA 
version 12.0 (Stata Corp, College Station, TX, USA).
Results
During a mean 14 years of follow-up and 8.6 million person-
years of observation, there were 2,333 CRC deaths (60% 
men) of which 1,607 were from colon cancer (57% men) 
and 726 from rectal cancer (67% men). Table 1 shows 
that the 40 years cohort was the largest study, contributing 
64% of participants and 37% of CRC deaths. The mean age 
at enrollment varied from 40 years in the Norwegian coun-
ties study to 48 years in the CONOR study. About 63% of 
all the participants were ever smokers at enrollment. For 
both sexes and in all surveys, current smokers had a shorter 
duration of education, were less physically active, and had 
a lower body mass index compared with never smokers (all 
P-values ,0.0001, data not shown).
Table 2 shows that male ever smokers had a 23% 
increased risk of dying from CRC (HR 1.23, CI 1.08–1.40) 
and male ever smokers included in the Norwegian counties 
study had an approximately 40% increased risk of CRC 
Table 1 Selected characteristics of the study population, stratified by cohort, among 602,242 Norwegian males and females 
(1972–2003) at enrollment











subjects 16,946 83,486 384,767 117,043 602,242
Person-years of follow-up 475,834 2,131,871 4,985,334 968,293 8,561,332
age (years, mean, sD) 45±6 40±7 43±5 48±14 44±8
age at CrC diagnosis among casesb  
(mean, sD)
68±8 63±9 57±10 68±12 62±11
age at death, all causesb (mean, sD) 70±8 64±9 61±13 76±13 66±12
age at CrC deathsb (mean, sD) 70±7 64±8 60±12 73±12 65±11
CrC deaths (n) 388 723 860 362 2,333
Colon cancer deaths (n) 238 468 624 277 1,607
rectal cancer deaths (n) 150 255 236 85 726
Year of birth, median (iQr) 1928 (1925–1931) 1938 (1932–1944) 1950 (1948–1954) 1950 (1941–1960) 1950 (1944–1954)
Follow-up years, median (iQr) 32 (24–33) 29 (20–30) 13 (10–16) 9 (6–10) 13 (9–17)
$13 years of educationb (%) 24 13 24 21 22
Body mass index (kg/m², mean, sD) 25±3 25±4 25±4 26±4 25±4
level of physical activity, heavyc (%) 20 21 28 33 28
smoking status
 never smokers (%) 21 36 36 41 37
 Ever smokers (%) 79 64 64 59 63
Notes: aincluded only men; bnot at enrollment; cheavy physical activity, ie, light sports or heavy gardening $4 hours per week, heavy exercise, or daily competitive sports.
Abbreviations: CrC, colorectal cancer; sD, standard deviation; iQr, interquartile range.





death (HR 1.46, 95% CI 1.12–1.89). The risk estimates for 
cigarette smoking and CRC death in male ever smokers did 
not reveal any significant results for other surveys compared 
with study-specific male never smokers. By survey, the trend 
test was significant for different smoking exposures and CRC 
mortality in men (except for age at smoking initiation) only 
in the Norwegian counties study.
Table 3 shows that women who were ever smokers had 
a 22% increased risk of death from CRC (HR 1.22, 95% 
CI 1.06–1.40) when compared with female never smokers. 
Female ever smokers included in the Norwegian counties 
study had a significant 30% increased risk of death from CRC 
(HR 1.32, 95% CI 1.05–1.64). As in men, the risk estimates 
for cigarette smoking and CRC death in female ever smokers 
were not significant for other surveys compared with study-
specific female never smokers. By survey, the trend test was 
significant for different smoking exposure and CRC mortality 
only for women in the Norwegian counties study.
Table 4 shows that the risk of death from rectal cancer 
was about 40% higher for male ever smokers (HR 1.43, 95% 
CI 1.14–1.81) compared with male never smokers. The risk 
estimates for smoking and colon cancer mortality and by 
location did not reveal any significant results among male 
ever smokers compared with male never smokers. The trend 
tests across different smoking exposure categories including 
never smokers as the reference group for age at smoking 
initiation, numbers of cigarettes smoked per day, numbers 
of years of smoking, and number of pack-years all yielded 
significant results for rectal cancer mortality among men 
(P,0.05, Table 4).
Table 5 shows that female ever smokers had a 26% 
increased risk of death from colon cancer (HR 1.26, 95% CI 
1.08–1.48) when compared with female never smokers. 
Female ever smokers had an almost 50% increased risk 
of death from proximal colon cancer (HR 1.49, 95% 
CI 1.20–1.87). The risk estimates for female ever smokers 
were not significant for distal colon cancer or rectal cancer 
deaths when compared with female never smokers. The trend 
tests across different smoking exposure categories including 
never smokers as the reference group for age at smoking 
initiation, numbers of cigarettes smoked per day, numbers 
of years of smoking, and number of pack-years all yielded 
significant results for colon cancer and proximal colon cancer 
mortality among women (P,0.05, Table 5).
These estimates did not differ materially when we 
excluded only cigar and pipe smokers from the analyses (data 
not shown). In the sensitivity analyses, the risk estimates 
of CRC mortality for ever smokers decreased among men 
(HR 0.84, 95% CI 0.60–1.18) and stayed basically the same 
although were no longer significant among women (HR 1.25, 
95% CI 0.89–1.74). Altogether, 86% of total CRC mortality 
cases and 78% of all follow-up were lost when we carried out 
analyses only for participants with information on alcohol 
use (data not shown).
A test for heterogeneity by sex was also significant 
for former smoking and risk of rectal cancer (Wald χ2, 
P=0.02), with a pronounced risk in men. Further, this test 
for heterogeneity by sex was statistically significant, showing 
increased risk among former, and ever smoking women and 
risk of proximal colon cancer mortality. The Wald test for 
heterogeneity was borderline significant for current smokers 
(Wald χ2, P=0.054).
Discussion
Our study shows that both male and female ever smokers 
have an increased risk of CRC mortality. There was a signifi-
cantly increased risk of mortality from rectal cancer among 
male smokers and a significantly increased risk of mortality 
from colon cancer (mainly of the proximal colon) in female 
smokers. The increased mortality risk for CRC overall was 
somewhat more pronounced for current smokers than for 
former smokers in both males and females.
Our study is a large, nationwide, prospective cohort 
study with virtually complete follow-up, and contains a large 
proportion of male and female ever smokers. Similarly, the 
longer follow-up period gives us more stable risk estimates. 
Smoking history was accessed at enrollment, which mini-
mizes recall bias. We also consider it to be a strength that we 
focused our analyses on comparisons between ever smokers 
and never smokers. We have previously reported an increased 
incidence of colon and rectal cancer among males and 
females who were ever smokers from the same cohort.12
The study has several limitations. The information on 
smoking habits was only available at baseline and not dur-
ing follow-up. Further, around 10% of Norwegian males and 
females are occasional smokers,10 and we lacked informa-
tion on passive smoking. Ever smokers have an increased 
risk of dying from other smoking-related diseases15,16 during 
follow-up due to competing risks for mortality. This could have 
decreased the impact of smoking and CRC mortality more 
among ever smokers compared with never smokers. Those 
who were occasional or passive smokers in our study are most 
likely included in the reference group, ie, the never smoker 
group, which might have biased our results by decreasing the 
risk estimates. We lacked information on alcohol consump-
tion for the majority of our study participants, and alcohol is 






























































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































Table 3 Multivariatea adjusted hrs and 95% Cis for colorectal cancer mortality among women (n=302,866), according to various 
measures of smoking exposure at enrollment, by surveys (1974–2003) with never smokers as the reference group
Smoking exposure Norwegian counties  
study (1974–1987)36–39 
n=41,573
40 years cohort  
(1985–1999)36,40,41 
n=199,730







HR 95% CI Cases 
n=418
HR 95% CI Cases 
n=181




never 147 1.00 ref 172 1.00 ref 98 1.00 ref 417 1.00 ref
Former 44 1.17 0.84–1.64 77 1.05 0.80–1.38 41 1.01 0.70–1.47 162 1.08 0.90–1.30
Current 136 1.38 1.08–1.75 169 1.30 1.03–1.63 42 1.12 0.76–1.65 347 1.30 1.12–1.52
P-trendb ,0.05 ,0.05 0.605 ,0.05
Ever 180 1.32 1.05–1.64 246 1.20 0.98–1.47 83 1.06 0.78–1.44 509 1.22 1.06–1.40
Ever smokersc 
 age at smoking initiation (years)
  $25 51 1.22 0.89–1.69 48 1.32 0.96–1.82 29 1.19 0.78–1.81 128 1.25 1.02–1.52
  20–24 53 1.63 1.18–2.24 62 1.32 0.97–1.80 18 0.83 0.50–1.39 133 1.31 1.07–1.61
  #19 32 1.31 0.88–1.96 68 1.14 0.83–1.55 31 1.09 0.69–1.72 131 1.20 0.97–1.48
  P-trendb ,0.05 ,0.05 0.673 ,0.05
 Cigarettes per day (n)
  1–9 82 1.27 0.97–1.67 70 1.09 0.82–1.44 32 0.82 0.54–1.23 184 1.10 0.92–1.31
  10–19 80 1.30 0.99–1.72 137 1.28 1.01–1.63 41 1.40 0.95–2.07 258 1.31 1.12–1.55
  $20 18 1.68 1.03–2.75 38 1.20 0.84–1.73 6 1.01 0.44–2.34 62 1.29 0.99–2.70
  P-trendb ,0.05 0.061 0.278 ,0.05
 Years of smoking (n)
  1–19 94 1.21 0.93–1.58 110 1.24 0.97–1.60 25 1.11 0.70–1.76 229 1.21 1.02–1.43
  20–29 79 1.47 1.10–1.93 115 1.13 0.87–1.46 23 1.17 0.72–1.89 217 1.27 1.07–1.51
  $30 7 1.38 0.64–2.98 20 1.31 0.80–2.12 29 0.94 0.61–1.44 56 1.11 0.83–1.48
  P-trendb ,0.05 0.168 0.970 ,0.05
 Pack-years of smokingd (n)
  0–9 105 1.21 0.94–1.56 98 1.06 0.82–1.36 31 0.95 0.63–1.44 234 1.09 0.93–1.29
  10–19 62 1.52 1.12–2.05 103 1.32 1.01–1.71 28 1.20 0.77–1.87 193 1.38 1.15–1.65
  $20 13 1.49 0.84–2.64 44 1.41 1.00–1.98 16 0.98 0.57–1.68 73 1.32 1.03–1.70
  P-trendb ,0.05 ,0.05 0.749 ,0.0001
Notes: aadjusted for age, body mass index, level of physical activity at enrollment, and duration of education; bnever smokers included in the model; ctotal numbers of ever 
smokers do not equal the total numbers in different smoking exposures due to missing data in different smoking exposure groups; dpack-years were calculated as number of 
cigarettes smoked per day, divided by 20 and multiplied by the number of years of smoking.
Abbreviations: CI, confidence interval; HR, hazards ratio; Ref, never smokers group.
an established risk factor for CRC.17 Alcohol consumption in 
Norway is higher among men than women,18 and lack of adjust-
ment for alcohol consumption could have inflated our risk 
estimations, especially for men. Interpretation of our subcohort 
findings indicated that men are more prone than women to the 
effects of alcohol, and this could be due to the fact that alcohol 
consumption is higher among men than women in Norway,18 
and they also suggest that women are more vulnerable to the 
adverse effects of smoking. Our subcohort results should be 
interpreted caution due to the fact that it included very few 
cases and any conclusions drawn need to be replicated in a 
larger sample size and with more detailed information on 
alcohol consumption. We also lacked information on tumor 
staging and molecular data.
Our findings are in agreement with two recent meta-
 analyses19,20 that reported a strong association between 
cigarette smoking and risk of CRC mortality. As in our study, 
these meta-analyses also reported a higher CRC mortality risk 
for current smokers than for former smokers. Our risk esti-
mates for colon and rectal cancer mortality were also higher 
among current smokers than in former smokers; these results 
are in accordance with a study reported by  Botteri et al.19 
The risk of dying from proximal colon cancer was higher 
among women in our cohort, and this could be due to the fact 
that women in our study were at increased risk for proximal 
colon cancer compared with men.12 The observed higher 
site-specific increased mortality risk could be a reflection 
of site-specific CRC risk in our cohort.
Previous studies that included both males and females by 
different smoking status have shown significantly increased 
risk estimates for CRC mortality among both current and 
former smokers21,22 and among current smokers alone.23 
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Further, two of these studies also reported an association 
between smoking and risk of CRC mortality by sex and 
showed a significantly increased risk of CRC mortality both 
for former and current smokers21 and for current smokers 
alone,23 among both males and females. Few studies examin-
ing the association of smoking and risk of CRC mortality 
among men by subsite found a significantly increased risk of 
both colon and rectal cancer mortality,24 while other studies 
found in significant increased risk of colon and rectal cancer 
mortality25 and only risk of colon cancer mortality26 among 
current and former smokers. Similarly, a study done only 
among women showed a significantly increased risk of CRC 
mortality among both former and current smokers.27 These 
studies did not report results by ever smoking status.
Smoking-related risk estimates for CRC mortality were 
reported to be higher than incidence risk estimates, especially 
among current smokers.19 One possible explanation could be 
the probability of CRC diagnosis at advanced stages among 
current smokers.28–30 Increased mortality could also be due to 
possible differences in health behavior between smokers and 
nonsmokers, because smokers may be less likely to receive 
preventive and curative care and may have a higher incidence 
of comorbid conditions such as cardiovascular diseases.20 
The higher risk of CRC mortality among  current smokers 
could be due to biological factors, potential  confounders, or 
a combination of these, as reported by Liang et al,20 or to a 
poorer response by current smokers to cancer treatment.31 
Smoking has been shown to increase mortality among 
patients with operable CRC.32 A recent study done by Gram 
et al also reported the pronounced risk of mortality from 
cancer, cardiovascular diseases, and respiratory diseases 
in current smokers compared with former smokers among 
middle-aged Norwegian women.15 The prevention, diagnosis, 
and treatment of CRC in recent years have improved in many 
aspects. More attention to early diagnosis and breakthroughs 
in treatment have contributed to decreased mortality and 
Table 4 Multivariatea adjusted hr estimates for colorectal cancer mortality by subsite and location with 95% Cis among men 
(n=299,376) according to various measures of smoking exposure at enrollment, compared with never smokers
Colon cancer deaths Proximal colon  
cancer deaths
Distal colon  
cancer deaths
Rectal cancer deaths
n=922 HR 95% CI n=416 HR 95% CI n=320 HR 95% CI n=485 HR 95% CI
Smoking status
never 215 1.00 ref 103 1.00 ref 77 1.00 92 1.00 ref
Former 311 1.13 0.95–1.35 131 0.99 0.76–1.28 123 1.29 0.97–1.73 151 1.33 1.02–1.73
Current 396 1.16 0.98–1.37 182 1.08 0.84–1.38 120 1.03 0.77–1.38 242 1.52 1.19–1.94
P-trendb 0.09 0.50 0.99 ,0.05
Ever 707 1.15 0.98–1.34 313 1.04 0.83–1.30 243 1.14 0.88–1.48 393 1.43 1.14–1.81
Ever smokersc
 age at smoking initiation (years)
  $25 83 1.09 0.84–1.41 36 0.98 0.67–1.45 30 1.16 0.76–1.79 54 1.62 1.15–2.27
  20–24 132 1.14 0.92–1.42 55 0.98 0.70–1.37 42 1.04 0.71–1.52 67 1.27 0.92–1.74
  #19 255 1.21 1.00–1.46 125 1.24 0.95–1.62 76 1.01 0.73–1.40 132 1.37 1.04–1.80
  P-trendb 0.38 0.818 0.517 ,0.05
 Cigarettes per day (n)
  1–9 158 1.05 0.85–1.29 70 0.94 0.69–1.28 60 1.18 0.84–1.67 91 1.37 1.02–1.84
  10–19 336 1.18 0.99–1.40 151 1.08 0.84–1.40 102 1.04 0.77–1.40 189 1.47 1.14–1.89
  $20 181 1.23 1.01–1.50 76 1.09 0.81–1.47 69 1.31 0.94–1.82 93 1.45 1.08–1.94
  P-trendb ,0.05 0.416 0.237 ,0.05
 Years of smoking (n)
  1–19 195 1.05 0.86–1.27 89 0.99 0.74–1.31 74 1.13 0.82–1.56 112 1.31 1.00–1.74
  20–29 285 1.13 0.95–1.36 117 0.95 0.73–1.25 104 1.21 0.89–1.63 163 1.41 1.09–1.83
  $30 213 1.29 1.06–1.59 101 1.27 0.94–1.71 62 1.08 0.75–1.54 108 1.66 1.23–2.24
  P-trendb ,0.05 0.261 0.454 ,0.05
 Pack-years of smokingd (n)
  0–9 194 1.06 0.87–1.29 94 1.05 0.79–1.40 74 1.16 0.84–1.60 111 1.33 1.01–1.77
  10–19 235 1.10 0.91–1.33 94 0.90 0.68–1.19 77 1.05 0.76–1.44 136 1.40 1.07–1.83
  $20 244 1.33 1.10–1.61 109 1.23 0.93–1.63 80 1.26 0.91–1.74 124 1.59 1.21–2.10
  P-trendb ,0.05 0.298 0.255 ,0.05
Notes: aadjusted for age, body mass index, level of physical activity at enrollment, and duration of education; bnever smokers included in the model; ctotal numbers of ever 
smokers do not equal the total numbers in different smoking exposures due to missing data in different smoking exposure groups; dpack-years were calculated as number of 
cigarettes smoked per day, divided by 20 and multiplied by the number of years of smoking.
Abbreviations: CI, confidence interval; HR, hazards ratio; Ref, never smokers group.





increased survival compared with earlier decades. Our find-
ing of decreased mortality risk estimations in the recent 
surveys, such as the CONOR study, compared with earlier 
ones, such as the Norwegian Counties Study, further sup-
ports this notion.
Conclusion
Smoking is associated with increased CRC mortality in both 
males and females. The risk of rectal and proximal colon 
cancer mortality, respectively, was most pronounced in male 
and female smokers.
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